BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 20547733)

  • 21. Hypoxia and TP53 deficiency for induced pluripotent stem cell-like properties in gastrointestinal cancer.
    Hoshino H; Nagano H; Haraguchi N; Nishikawa S; Tomokuni A; Kano Y; Fukusumi T; Saito T; Ozaki M; Sakai D; Satoh T; Eguchi H; Sekimoto M; Doki Y; Mori M; Ishii H
    Int J Oncol; 2012 May; 40(5):1423-30. PubMed ID: 22293932
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Endogenous KLF4 expression in human fetal endothelial cells allows for reprogramming to pluripotency with just OCT3/4 and SOX2--brief report.
    Ho PJ; Yen ML; Lin JD; Chen LS; Hu HI; Yeh CK; Peng CY; Lin CY; Yet SF; Yen BL
    Arterioscler Thromb Vasc Biol; 2010 Oct; 30(10):1905-7. PubMed ID: 20689077
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Induced pluripotent stem cells.
    Zaehres H; Kim JB; Schöler HR
    Methods Enzymol; 2010; 476():309-25. PubMed ID: 20691874
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oct4 and klf4 reprogram dermal papilla cells into induced pluripotent stem cells.
    Tsai SY; Clavel C; Kim S; Ang YS; Grisanti L; Lee DF; Kelley K; Rendl M
    Stem Cells; 2010 Feb; 28(2):221-8. PubMed ID: 20014278
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterization of gastrulation-stage progenitor cells and their inhibitory crosstalk in human embryoid bodies.
    Kopper O; Giladi O; Golan-Lev T; Benvenisty N
    Stem Cells; 2010 Jan; 28(1):75-83. PubMed ID: 19921748
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Yamanaka factors critically regulate the developmental signaling network in mouse embryonic stem cells.
    Liu X; Huang J; Chen T; Wang Y; Xin S; Li J; Pei G; Kang J
    Cell Res; 2008 Dec; 18(12):1177-89. PubMed ID: 19030024
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differentiation of reprogrammed mouse cardiac fibroblasts into functional cardiomyocytes.
    Jiang B; Dong H; Li Q; Yu Y; Zhang Z; Zhang Y; Wang G; Zhang Z
    Cell Biochem Biophys; 2013 Jun; 66(2):309-18. PubMed ID: 23212180
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Induction of pluripotent stem cells from primary human fibroblasts with only Oct4 and Sox2.
    Huangfu D; Osafune K; Maehr R; Guo W; Eijkelenboom A; Chen S; Muhlestein W; Melton DA
    Nat Biotechnol; 2008 Nov; 26(11):1269-75. PubMed ID: 18849973
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Stem cells. A new year and a new era.
    Pera MF
    Nature; 2008 Jan; 451(7175):135-6. PubMed ID: 18185576
    [No Abstract]   [Full Text] [Related]  

  • 30. The magic of four: induction of pluripotent stem cells from somatic cells by Oct4, Sox2, Myc and Klf4.
    Qi H; Pei D
    Cell Res; 2007 Jul; 17(7):578-80. PubMed ID: 17632550
    [No Abstract]   [Full Text] [Related]  

  • 31. Effective generation of iPS cells from CD34+ cord blood cells by inhibition of p53.
    Takenaka C; Nishishita N; Takada N; Jakt LM; Kawamata S
    Exp Hematol; 2010 Feb; 38(2):154-62. PubMed ID: 19922768
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Landmark approach to generating human stem cells.
    Daubman S
    Circ Res; 2011 Jan; 108(2):161-3. PubMed ID: 21252149
    [No Abstract]   [Full Text] [Related]  

  • 33. Generation of p53-deficient induced pluripotent stem cells from mouse embryo fibroblasts.
    Alexandrova EM; Moll UM
    Methods Mol Biol; 2013; 962():157-64. PubMed ID: 23150445
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficient and rapid generation of induced pluripotent stem cells from human keratinocytes.
    Aasen T; Raya A; Barrero MJ; Garreta E; Consiglio A; Gonzalez F; Vassena R; Bilić J; Pekarik V; Tiscornia G; Edel M; Boué S; Izpisúa Belmonte JC
    Nat Biotechnol; 2008 Nov; 26(11):1276-84. PubMed ID: 18931654
    [TBL] [Abstract][Full Text] [Related]  

  • 35. NANOG is a key factor for induction of pluripotency in bovine adult fibroblasts.
    Sumer H; Liu J; Malaver-Ortega LF; Lim ML; Khodadadi K; Verma PJ
    J Anim Sci; 2011 Sep; 89(9):2708-16. PubMed ID: 21478453
    [TBL] [Abstract][Full Text] [Related]  

  • 36. iPS programmed without c-MYC yield proficient cardiogenesis for functional heart chimerism.
    Martinez-Fernandez A; Nelson TJ; Yamada S; Reyes S; Alekseev AE; Perez-Terzic C; Ikeda Y; Terzic A
    Circ Res; 2009 Sep; 105(7):648-56. PubMed ID: 19696409
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MicroRNA-145 regulates OCT4, SOX2, and KLF4 and represses pluripotency in human embryonic stem cells.
    Xu N; Papagiannakopoulos T; Pan G; Thomson JA; Kosik KS
    Cell; 2009 May; 137(4):647-58. PubMed ID: 19409607
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Induced pluripotency and cellular alchemy.
    Perry AC
    Nat Biotechnol; 2006 Nov; 24(11):1363-4. PubMed ID: 17093483
    [No Abstract]   [Full Text] [Related]  

  • 39. Reprogramming of mouse renal tubular epithelial cells to induced pluripotent stem cells.
    Wang WW; Wang W; Jiang Y; Han GF; Lu S; Li G; Zhang J
    Cytotherapy; 2013 May; 15(5):578-85. PubMed ID: 23415920
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gene expression of OCT4, SOX2, KLF4 and MYC (OSKM) induced pluripotent stem cells: identification for potential mechanisms.
    Cai Y; Dai X; Zhang Q; Dai Z
    Diagn Pathol; 2015 Apr; 10():35. PubMed ID: 25907774
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.